Goodsleeper

Goodsleeper is a Polish digital health company focused on addressing the widespread issue of insomnia through a scientifically validated mobile application. The firm operates in the digital therapeutics market, providing a solution for individuals experiencing difficulties with sleep. Its core product is a class 1 medical device that delivers a digital version of Cognitive-Behavioral Therapy for Insomnia (CBT-I), which is recommended as a primary treatment method for insomnia.

The application was developed by a distinguished interdisciplinary team, including Dr. Małgorzata Fornal-Pawłowska, a psychotherapist recognized as a pioneer of CBT-I in Poland, and Dr. Michał Skalski, a prominent psychiatrist and authority in Polish sleep medicine. This foundation in expert knowledge is a key aspect of the company's offering. The effectiveness of the digital therapy program was validated in a randomized study conducted in collaboration with SWPS University, which showed a significant reduction in insomnia symptoms among users.

The business model appears to be direct-to-consumer, offering the application, known as Terapiabezsennosci.pl in Poland, to the public. Goodsleeper is also actively pursuing B2B channels, finalizing collaborations with medical centers and insurance companies. Revenue is generated through access to its therapeutic programs. A significant milestone was a funding round in 2022, where the company raised over 1.2 million PLN from the LT Capital fund and the pharmaceutical company Adamed Pharma. This capital was earmarked for enhancing the application, including launching a version 2.0 with a full mobile experience and developing an English-language version to expand its market reach. In a notable 2022 partnership, Goodsleeper and Adamed Pharma launched a Ukrainian-language version of the app to support individuals affected by the war crisis.

The product itself is a comprehensive 6-week program that guides users through the principles of CBT-I without the direct need for a therapist. It includes features for monitoring sleep patterns, learning cognitive-behavioral techniques such as stimulus control and sleep restriction, and accessing educational content about sleep hygiene. By digitizing a proven therapeutic method, Goodsleeper aims to overcome common barriers to treatment, such as long waiting times for specialists and the high cost of private therapy. Keywords: digital therapeutics, sleep medicine, cognitive behavioral therapy, insomnia treatment, CBT-I, digital health Poland, MedTech, mental wellness, mobile health, sleep app, telemedicine, SWPS University, Adamed Pharma, Dr. Małgorzata Fornal-Pawłowska, Dr. Michał Skalski, health technology, sleep aid, online therapy, behavioral health, e-health